Back to search

Article

Targeting Glioblastoma Cell State Plasticity for Enhanced Therapeutic Efficacy

2025-09-12

Abstract excerpt

<h4>Summary</h4> Glioblastoma (GBM) is the most common and deadly primary brain cancer, with limited therapeutic options. Treatment failure has been associated with intratumoral heterogeneity and the acquisition of a pronounced mesenchymal-like (MES-L) phenotype after recurrence. Here, we have screened a panel of drugs with diverse mechanisms of action across two patient-derived glioblastoma stem cells (GSCs) to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1877d2c3-922e-54d2-952e-ddba39a43ebf
DOI
10.1101/2025.09.08.674897
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting Glioblastoma Cell State Plasticity for Enhanced Therapeutic EfficacyDOI 10.1101/2025.09.08.674897
Select a neighboring publication to make it the new centre.